Highlights From ISPE Knowledge Network
Explore webinars, training PE articles, and more relevant to your job function.
These top focus areas bring the most relevant ISPE content to the forefront of your browsing experience. Explore webinars, training, PE articles and more.
Facilities & Equipment
- Good Practice Guide: SMEPAC - Standardized Methodology for the Evaluation of Pharma Airborne Particle Emissions from Containment Systems 3rd Edition
- 2024 FOYA Banquet Recap: Celebrating Excellence and Tips for Submitting to the 2025 Facility of the Year Awards
- Process Considerations When Designing mAbs Production Facilities
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
Information Systems
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Unlock the Future of Pharmaceutical Manufacturing: Learn from Industry Leaders at the 2024 ISPE Pharma 4.0™ and Annex 1 Conference
Management
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Overcoming Fear of the Engineer-Procure-Construct (EPC) Model to Recognize Project Execution Benefits
Product Development
- Advancing Precision Medicine with ADCs and Radiopharmaceuticals
- Process Considerations When Designing mAbs Production Facilities
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
Quality
Regulatory
- EMA Executive Director Discusses the Future of Innovation and Regulation
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
Supply Chain
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Explore the Possibilities of Pharmaceutical Advancement with Digital Tools, Including AI/ML at the 2024 ISPE Annual Meeting & Expo
Facilities & Equipment
Information Systems
Management
Product Development
Quality
Regulatory
Supply Chain
- Good Practice Guide: SMEPAC - Standardized Methodology for the Evaluation of Pharma Airborne Particle Emissions from Containment Systems 3rd Edition
- 2024 FOYA Banquet Recap: Celebrating Excellence and Tips for Submitting to the 2025 Facility of the Year Awards
- Process Considerations When Designing mAbs Production Facilities
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Unlock the Future of Pharmaceutical Manufacturing: Learn from Industry Leaders at the 2024 ISPE Pharma 4.0™ and Annex 1 Conference
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Overcoming Fear of the Engineer-Procure-Construct (EPC) Model to Recognize Project Execution Benefits
- Advancing Precision Medicine with ADCs and Radiopharmaceuticals
- Process Considerations When Designing mAbs Production Facilities
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Post Approval Changes and ICH Q12
- EMA Executive Director Discusses the Future of Innovation and Regulation
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Global Adoption Status and Implementation of ICH Guidelines Q12, Q2(R2), and Q14
- FDA CDER Associate Director Speaks About Regulatory Reliance and Agility
- A Message from the 2025 ISPE Aseptic Conference Chair
- Explore the Possibilities of Pharmaceutical Advancement with Digital Tools, Including AI/ML at the 2024 ISPE Annual Meeting & Expo
Access Your Member Benefits
Collaborate on a global scale, drive innovation, lead conversations, and more.
Become a member of ISPE.
Explore the benefits of ISPE membership.
Explore the benefits of ISPE membership.
Increased Access to Good Practice Guides Access to Good Practice Guidance Documents
With an ISPE membership, you’ll gain access to 24+ Good Practice Guides.
Get Involved
Enhance your ISPE Membership through involvement at the local and international level. Through knowledge sharing, networking, and engaging thought leadership, you can contribute to shaping the future of the pharmaceutical industry.
ISPE Membership
ISPE is the most dynamic community in the industry, with a global network of 20,000+ professionals spanning the complete pharmaceutical lifecycle. With resources available for all stages of your career, an ISPE Membership is a career game changer.
Community Discussions
Community Discussions
Dec 20, 2024
Dec 19, 2024
GAMP®
Dec 18, 2024
Dec 16, 2024
Biotechnology
Containment
Dec 11, 2024
Data Integrity
Videos
Recommended
Latest
Latest Magazine Issue
Plastic Process Waste in Biopharmaceutical Manufacturing Cover: This article presents a comprehensive analysis of plastic waste generation in the biopharmaceutical industry, focusing on using single-use technologies (SUT...
Corporate Partners
View Corporate Partners
